Clinical Recognition of Diabetic Ketoacidosis
A patient presenting with diabetic ketoacidosis can be identified clinically by the combination of characteristic symptoms (polyuria, polydipsia, nausea/vomiting, abdominal pain), physical findings (Kussmaul respirations, dehydration signs, altered mental status), and rapid evolution of illness (typically <24 hours), which should prompt immediate laboratory confirmation of the diagnostic triad. 1
Classic Clinical Presentation
Cardinal Symptoms
- Polyuria, polydipsia, and polyphagia with weight loss are the most frequently reported symptoms in DKA 1, 2
- Gastrointestinal symptoms including nausea, vomiting, and abdominal pain are extremely common, with up to 25% experiencing coffee-ground emesis 1
- Weakness, malaise, and severe fatigue are frequently present 1, 2
- Dyspnea may be reported as the patient attempts to compensate for metabolic acidosis 2
- Preceding febrile illness is often part of the history, as infection is a common precipitating factor 2
Physical Examination Findings
- Kussmaul respirations (deep, labored breathing pattern) are the hallmark sign indicating metabolic acidosis 1
- Dehydration signs including poor skin turgor, dry mucous membranes 1
- Tachycardia and hypotension result from volume depletion 1
- Altered mental status ranging from full alertness to profound lethargy, stupor, or coma depending on severity 1, 3
- Fruity odor on breath from acetone 4
- Normothermia or hypothermia may be present even with underlying infection, with hypothermia being a poor prognostic sign 1
Temporal Evolution
- DKA typically evolves rapidly, usually within less than 24 hours, which distinguishes it from hyperosmolar hyperglycemic state that develops over days to weeks 1
- The first symptoms usually come on gradually over hours or days and include drowsy feeling, flushed face, thirst, and loss of appetite 4
- Heavy breathing and rapid pulse are more severe symptoms that develop as acidosis worsens 4
Critical Clinical Pitfall: Euglycemic DKA
Be aware that DKA can present with normal or near-normal glucose levels (<250 mg/dL), particularly in patients taking SGLT2 inhibitors, and this can lead to delayed diagnosis. 1, 3
High-Risk Scenarios for Euglycemic DKA
- SGLT2 inhibitor use is the most important modern risk factor 1, 3
- Pregnancy 1
- Reduced food intake or starvation 1
- Alcohol use 1
- Liver failure 1
- Recent insulin administration 5
Clinical Approach When Euglycemic DKA is Suspected
- Maintain high suspicion for DKA in any diabetic patient with metabolic acidosis and ketosis, regardless of glucose level 6
- The same clinical symptoms and physical findings apply, but the absence of marked hyperglycemia may mislead clinicians 5
- Even hypoglycemia can occur concurrently with DKA, particularly with SGLT2 inhibitors 6
Severity Assessment by Mental Status
- Mild DKA: Patient is alert 3
- Moderate DKA: Patient is alert or drowsy 3
- Severe DKA: Patient exhibits stupor or coma 3
Common Precipitating Factors to Identify
- Infection is the most common precipitating factor 1
- New-onset type 1 diabetes (DKA may be the initial presentation, especially in children) 1, 2
- Insulin omission or inadequate insulin dosing 1
- Cerebrovascular accident or myocardial infarction 1
- Drug use including corticosteroids, thiazides, sympathomimetic agents 1
- Alcohol abuse 1
- Pancreatitis 1
Immediate Laboratory Confirmation Required
While clinical recognition is crucial, diagnosis cannot be made on clinical grounds alone and requires immediate laboratory testing to confirm the diagnostic triad: